Cargando…

Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas

INTRODUCTION: Human epidermal growth factor receptor (HER)-2 overexpression or gene amplification is more common in high-grade or type 2 endometrial carcinomas. We assessed the discordance of HER-2 expression between primary and metastatic or recurrent endometrial carcinomas. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Rina, Hasegawa, Kiyoshi, Ishii, Risa, Owaki, Akiko, Torii, Yutaka, Oe, Shuko, Hirasawa, Hiroshi, Kobayashi, Yoichi, Udagawa, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742156/ https://www.ncbi.nlm.nih.gov/pubmed/23950654 http://dx.doi.org/10.2147/OTT.S47504

Ejemplares similares

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012)

Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma
por: Yang, Wei-Ning, et al.
Publicado: (2014)

Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer
por: Hipp, Susanne, et al.
Publicado: (2009)

HER2 Amplification in p53-Mutated Endometrial Carcinomas
por: Balestra, Ambre, et al.
Publicado: (2023)

Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
por: Ni, Shujuan, et al.
Publicado: (2022)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

TOP2A Amplification and Overexpression in Hepatocellular Carcinoma Tissues
por: Panvichian, Ravat, et al.
Publicado: (2015)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

Epidermal Overexpression of Xenobiotic Receptor PXR Impairs the Epidermal Barrier and Triggers Th2 Immune Response
por: Elentner, Andreas, et al.
Publicado: (2017)

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer
por: Mukai, Hirofumi, et al.
Publicado: (2016)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
por: Bar, Julia K, et al.
Publicado: (2012)

The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors
por: Hou, Helei, et al.
Publicado: (2019)

FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance
por: Yu, Yang, et al.
Publicado: (2023)

Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
por: Iqbal, Nida, et al.
Publicado: (2014)

Low frequency of HER2 amplification and overexpression in early onset gastric cancer
por: Moelans, Cathy B., et al.
Publicado: (2011)

Involvement of glutamine synthetase 2 (GS2) amplification and overexpression in Amaranthus palmeri resistance to glufosinate
por: Noguera, Matheus M., et al.
Publicado: (2022)

Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer
por: Fue, Misaki, et al.
Publicado: (2018)

Detecting Human Epidermal Growth Factor Receptor 2 (HER2) Amplification: Proof of Concept of an Alternative Approach
por: Mudgal, Shikha, et al.
Publicado: (2023)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer
por: Hashimoto, Chiaki, et al.
Publicado: (2018)

Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification
por: Ren, Yongxin, et al.
Publicado: (2017)

Stomatal development in the context of epidermal tissues
por: Torii, Keiko U
Publicado: (2021)

Positive and Negative Regulators of Sclerostin Expression
por: Iwamoto, Rina, et al.
Publicado: (2022)

Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
por: YOSHIMOTO, Sho, et al.
Publicado: (2020)

Human epidermal growth factor 2 overexpressed alpha-fetoprotein-producing-gastric cancer
por: Shimizu, Hiroko, et al.
Publicado: (2023)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancer
por: Minashi, Keiko, et al.
Publicado: (2021)

Evaluation of the Safety and Efficacy of Modified Laparoscopic Suture Rectopexy for Rectal Prolapse
por: Takahashi, Rina, et al.
Publicado: (2023)

The anti‐obesity and anti‐diabetic effects of the edible seaweed Gloiopeltis furcata (Postels et Ruprecht) J. Agardh in mice fed a high‐fat diet
por: Murakami, Shigeru, et al.
Publicado: (2022)

Prognostic and Clinical Significance of Cyclooxygenase-2 Overexpression in Endometrial Cancer: A Meta-Analysis
por: Li, Mingli, et al.
Publicado: (2020)

Efficacy of liquid‐based genetic diagnosis of endometrial cancer
por: Matsuura, Motoki, et al.
Publicado: (2018)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
por: Horimoto, Yoshiya, et al.
Publicado: (2022)

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
por: Saito, Ayumi, et al.
Publicado: (2021)

Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
por: Yu, Qiong, et al.
Publicado: (2014)

ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma
por: Murata, Yoshihiko, et al.
Publicado: (2014)

Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis
por: Itkin, Boris, et al.
Publicado: (2021)

The Luminosity Curve of the Deuteranomalous Fovea
por: Alpern, Mathew, et al.
Publicado: (1968)

The Luminosity Curve of the Protanomalous Fovea
por: Alpern, Mathew, et al.
Publicado: (1968)

Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
por: Shin, Daniel Sanghoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fbbmtfg0guf1ou5k3l5i5jcjon